J&J And Teva Vs Oklahoma State Opioid Trial To Begin
J&J And Teva Vs Oklahoma State Opioid Trial To Begin
Introduction
A trial will begin on May 28, Tuesday, between Oklahoma State Vs Johnson & Johnson and Teva Pharmaceutical Industries over alleged link to opioid epidemic. A $17 billion lawsuit filed by the Oklahoma Attorney General Mike Hunter will be the first to go to trial of more than 2,000 lawsuits filed by state and local governments.
The trial will be held in front of Cleveland County District Judge Thad Balkman and is expected to last for eight weeks. The opioid epidemic has been linked to a record 47,600 overdose deaths in 2017, according to the U.S. Centers for Disease Control and Prevention. The state also claims the manufacturers deceptively marketed opioids, whereas the defendants denied any wrongdoing, claiming the state lacks proper evidence.
Similar claims against OxyContin maker Purdue Pharma LP have been resolved by the state in March for $270 million. More than 1,600 cases over the opioid crisis are filed largely by local governments, Native American tribes, and hospitals. The first trial in the MDL No. 2804 is set to start in October 2019.
Comments
Latest News
NC to Get $150M to Boost Opioid Treatment, Recovery
Categories: Opioids
North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid…
SRI Gets FDA OK for High-Dose Naloxone Trial
Categories: Opioids
SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.
The approval was granted under an Investigational New Drug (IND)…
Spokane County to Get $5M in New Opioid Settlement
Categories: Opioids
Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.
The agreement addresses the company’s role in fueling…